Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial

Study:

Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial

Rationale:

n/a

Purpose:

Evaluate the safety and efficacy of the Protege Stent and Spider Device in the treatment of common and/or internal carotid artery stenoses for subjects that are high risk for carotid endarterectomy.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Carotid Artery Disease Device: PROTÉGÉ® GPS™ and PROTÉGÉ® RX Carotid Stent Systems and Spider Embolic Protection Device Phase 3

Verified by ev3 Endovascular, Inc. December, 2008

Sponsored by: ev3 Endovascular, Inc.
Information provided by: ev3 Endovascular, Inc.
ClinicalTrials.gov identifier: NCT00619775

Study Type: Interventional

Study Design: Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Cleveland Clinic Foundation
Cleveland, Ohio 44111
United States

Robert Safian, MD., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site